BioNano Genomics, Inc. (BNGO) Reports Q2 Revenue of $2.5M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Grand Canyon Education places CFO on leave amid stock trade probe
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- Funds sell $44bn in semiconductors on AI concerns
Bionano Genomics Reports Second Quarter 2021 Financial Results and Highlights Recent Business Progress
August 4, 2021 4:05 PM EDT226% year-over-year total revenue increase driven by growth in the Saphyr installed baseAll 2021 milestones on trackStrong balance sheet with $333 million in cash as of June 30, 2021Conference call today, Wednesday, August 4, at 4:30 pm ET
SAN DIEGO, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today reported financial results and business achievements for the second quarter ended June 30, 2021 and highlighted recent corporate... More
